World EPA Congress 2023 | Terrapinn | 20 March 2023 | Amsterdam RAI, Europaplein 24, 1078 GZ Amsterdam, Netherlands

World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, multiple streams and over 1200 attendees from pharma, biotech and Payers/HTA’s.

Covering all the big topics:
• Market Access & Pricing
• Evidence
• Rare Diseases
• Advanced Therapies
• Affordability
• HTA/Payer
• Big Data Analytics
• Emerging Markets
• Patient Advocacy
• Medical Devices

2023 Speakers

Harblas Ahir, Global Market Access, MSD

David Alderson, Project Director, Strategic Market Access, Cogentia Healthcare Consulting

Omar Ali, Visiting Lecturer, University of Portsmouth

Luigi Angelillo, Director, Market Access EMEA, Argenx

Ad Antonisse, Director Market Access & External Affairs, AstraZeneca BV

Emanuele Arca, Research Consultant – SMA & PCO, OPEN Health

Fausto Artico, Global R&D Tech Head of Innovation & Data Science, GSK

Marnix Artz, Head of Patient Access, Pricing & Public Affairs, Netherlands, Merck Group

Cecilie Astrup, Health economist, Amgros I/S

Yumi Asukai, Senior Director, Gilead Sciences Ltd

Nico Bacharidis, Chief Commercial Officer, Cube RM

Sumeet Bakshi, Senior Vice President, Real World Evidence, Lifescience Dynamics

Andy Ballantyne, VP Market Access, Ipsos Healthcare

Ms Dorothee Bartels, Associate Professor, Hannover medical school

Dorothee Bartels, Global Head RWE, UCB

Fabienne Bartoli, Director-General, French National Authority for Health

Alexander Bastian, VP Value & Market Access, A.M. Pharma

Maeva Bavoux, Consultant, Lifescience Dynamics

Catherine Beecher, Partner, Red Nucleus

Tomer Ben Zaken, Head of Sick Funds Access, AbbVIe

Nadia Benhadi, Eu Market Access And Pricing Director, GlaxoSmithKline

Nick Besseling, Manager Value Strategies & Agreements, AstraZeneca

Jesper Bjerggren, European Market Access Lead Respiratory/Digital Health, TEVA pharmaceuticals

Marie-Sharmila Blandino, Global Integrated Access Strategy Lead at Amgen and Vice-Chair of EFPIA Oncology Platform, Amgen

Axel Boehnke, Director Market Access EU North, PTC Therapeutics

Amanda Bok, Chief Executive Officer, European Haemophilia Consortium

thomas bols, head of government affairs and patient advocacy, PTC Therapeutics

Vidya Breeveld, Founder, Transmineo

Alberto Briones, Senior Consultant, Lifescience Dynamics

Sangeeta Budhia, VP, Pricing & Market Access, Parexel

Rob Burley, Director Of Campaigns, Care And Support, The Muscular Dystrophy U.K.

Astrid Buys, Global Head of Tenders & Pricing, Bavarian Nordic A/S

David Carr, Senior Director of Global Pricing & Market Access, PRECISIONadvisors

Sandro Cesaro, Head of Europe Market Access & Pricing, AstraZeneca

Catherine Chamoux, Consultant, Aesara

Mata Charokopou, Global Payer Strategy, UCB

Helene Chevrou-Severac, HEOR RWE Centre of Excellence Head, International & Japan, Alexion – AstraZeneca Rare Disease

José Luis Sánchez Chorro, Market Access Director Spain and Portugal, Jazz Pharmaceuticals

Sally Chung, VP, Head of Market Access & Pricing Europe, GSK

Friso Coerts, Market Access & HTA Manager, Pfizer

Jean-Philippe Combal, Co-Founder And Chief Executive Officer, Vivet Therapeutics

Stephen Connell, Director Payer Insights & Access, Pfizer Ltd

Craig Currie, Chief Scientific Officer, Human Data Sciences

Thomas Daniel, Business Development Manager, Vivet Therapeutics

Rossella Di Bidino, HTA expert, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Anna Dickinson, Senior Researcher, Science and Technology, Onward

Toon Digneffe, Head Public Affairs & Public Policy, Takeda

Marcus Droege, Vice President, Global Value & Market Access, Passage Bio

Gilles Ducorroy, Global Head of RWE Services, Novartis

Gina Ewy, VP Global Market Acce, Hansa Biopharma

Stefaan Fiers, Head of Corporate Communication, Public Affairs & Patient Advocacy, Belgium, Takeda

Ana Filipa Fonseca, Global Value & Access Director - Early Assets, Radioligand Therapy, Novartis

Graham Foxon, Managing Director, Remap Consulting

Stefan Franzen, Director, Medical & Payer Evidence Statistics, AstraZeneca

Neil Gallagher, Managing Economist, Copenhagen Economics

Pat Garcia-Gonzalez, Chief Executive Officer, THE MAX FOUNDATION

Sandra Garitonandía, LS Industry Principal EMEA, Vistex GmbH

Philippe Ghyssels, VP Corporate and Global Public Affairs, Ipsen

Fabrizio Gianfrate, Full Pro. of Health Economics and Outcome Research, University of Ferrara

Ramiro Gilardino, Global HTA & Access Policy Lead, MSD

Christoph Glaetzer, Chief Global Value and Access Officer, The Janssen Pharmaceutical Companies of Johnson & Johnson

Denise Globe, Head Global Health Economics and Outcomes Research Center of Excellence, Gilead Sciences

Josie Godfrey, Co-Founder and Chief Executive Officer, Realise Advocacy

Wim Goettsch, Associate Professor of HTA, Utrecht Centre for Pharmaceutical Policy and Regulation

Wyatt Gotbetter, SVP, WW Head of Access Consulting, Parexel

Alicia Granados, Head, Global Rare Diseases Scientific Advocacy, SANOFI

Pina Haberl, Senior Director, Global Market Access, Partners4Access

Gunter Harms, Senior Market Access Director, Novartis Gene Therapies

Sabina Heinz, Senior Principal Market Access, Ipsos Healthcare

Birgit Holz, Global Head of Contracting Innovation, Sanofi

Kirsty Hoyle, Chief Executive Officer, Metabolic Support UK

Giorgio Iotti, Head Of Program Leadership And Control, Rare Disease Unit, Chiesi Farmaceutici SpA

Amy Israel, Vice President and Global Head, Oncology Policy & Healthcare Systems, Novartis

Jayasree Iyer, CEO, Access to Medicine Foundation

Shrividya Iyer, Executive Director, Global RWE & US HEOR, Eisai

Daniel Jackson, Global Head of Market Access Policy, UCB

Saira Jan, Vice-President & Chief Pharmacy Officer, Blue Cross Blue Shield of New Jersey

Shalini Jayasekar Zurn, Senior Advocacy Manager, Union for International Cancer Control

Priti Jhingran, VP, Evidence Strategy, Genesis Research

Pall Jonsson, Programme director for Data, NICE Australia Pty Ltd

Madhu Kabra, Global Director HEOR, MKGlobal

Gomathi Kaliappan, Health Systems Strategy Leader - Global Access, Roche

Lisette Kaskens, Director Market Access for Europe, Latam and Canada, Ferring Pharmaceuticals

Nadia Kaskure, Value Strategy Lead, novo nordisk

Tom Kelly, Associate Director, Dolon

Francesca Kessler, Analyst, LOGEX B.V.

Jelle Kleijn, Global Head of Acanthamoeba Keratitis, SiFi

Linda klein Holkenborg, Medical Advisor, CZ

Diane Kleinermans, President of the Commission of Drugs Reimbursement, Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV)

Jolanda Koenders, Head Of Patient Value And Access, Takeda

Simone Koole, Medical advisor, ONVZ

Augusta Elizabeth Koroma, Chief Executive Officer, Sickle cell Intervention U.K

Aleksandra Krygiel-Nael, Head of Government Affairs and Policy, Medical Devices, Johnson & Johnson

Maria Kubin, Vice President of Global Market Access, Bayer Healthcare Ag

Hannah Kurth, Global Value and Access Lead, Horizon Therapeutics

Simon Lande, Chief Executive Officer, HealthLumen

Timothy Lenehan, CVP Global Evidence, Pricing and Access, Novo Nordisk

Giovanny Leon, Global Price Affordability & Early Access Executive Director, Novartis AG

Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer

Gavin Lewis, Vice President Global Head of Market Access, Amgen

Elena Lungu, Manager of Policy Development, Patented Medicine Prices Review Board, Government of Canada

Richard Macaulay, Vice President, PRECISIONadvisors

James Maddocks, International Policy Advisor, NHS Confederation

Victor Maertens, Government Affairs Manager, EUCOPE

Joerg Mahlich, Market Access and Government Affairs Lead, Miltenyi Biomedicine GmbH

Marco Marchetti, Director of Health Technology Assessment Unit, National Agency for Regional Care Services, Agenzia Nazionale per i Servizi Sanitari Regionali- Agenas

Marisca Marian, Market Access Strategy Leader, Bayer

Jeff Martin, VP Pricing & Deal Economics, EQRx

Linda McNamara, Senior Director, Payer Value and Patient Access, Kyowa Kirin GmbH

Vanessa Mirsky, Senior Director of Corporate Strategy and Global Payer Partnerships, EQRx, Inc.

Rasha Mokaddem, Market Access Director, Johnson & Johnson

Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine

Tal Morginstin, Director, HTA division, Ministry of health

Frederik Mortensen, Head of Market Access, Novartis Oncology Netherlands, Novartis

Mr Andrew Mumford, Chief Executive Officer, Initiate Consultants

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Bertalan Nemeth, Principal Researcher, Syreon Research Instittue

Lisette Nientker, Associate Director, OPEN Health

Enkeleida Nikai-Fitzgerald, Vice President, Global Real-World Evidence (RWE), Global Commercial Data Science, Janssen Pharmaceutical

Esther Nzenza, CEO and Founder, DECISIVE CONSULTING LTD

Andrew Olaye, Head of EMEA Market Access, Orchard Therapeutics Ltd

Melvin Olson, Global Head Integrated Evidence Strategy and Innovation, Novartis

Susanne Osanto, Professor of Oncology, LUMC

Gavin Outteridge, Managing Director - AESARA Europe, Aesara

Mario Ouwens, Group Director Medical & Payer Evidence Statistics, AstraZeneca

Sandra Paci, Global Market Access And Pricing Director, Argenx

Ana Palma, Senior Director Global Head of Patient Access & Access Policy, SOBI

Elena Panitti, Global Head Real World Evidence Excellence, Novartis

Michela Pantaleoni, Chief Market Access Officer, Napo Therapeutics

Arun Parekkat, European Commercial & UK Country Lead, LOGEX B.V.

Marta Pastor, Economic Senior Consultant, Catalan Health Service

Preeti Patel, CEO & Founder, Gpi

Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim

Lara Pippo, Head Of Market Access, Italy, CSL Behring

Sandra Pisek, Head Established Products, Europe, Sandoz

Anke Pisters-van Roy, MD, CZ

Ana Plata, Global Pricing Head, AstraZeneca

Mary Lynne Van Poelgeest-Pomfret, President, President of the World Federation for Incontinence and Pelvic Pain - WFIP

Ludovica Polverino, Market Access Director, Daiichi Sankyo Development Ltd

Fleur Pool, Medical Access Manager, Novartis Pharma B.V. NL

Luis Prieto Rodriguez, Global Real-World Evidence Director, Novartis

Sonia Pulido, HTA Co-ordinator, Spanish Medicines Agency

Sreeram Ramagopalan, Global Head Real-World Evidence (Market Access), Roche

Nuno Prego Ramos, Chief Executive Officer, cellmabs

Marco Rauland, Vice President Global Market Access & Pricing - Strategic Planning, Merck Group

Laurene Redding, Head, Value, Access & Policy, Canada, BeiGene

Peny Retsa, Market Access and External Relations Director, AbbVIe

Sybille Riou, Global Market Access Manager, Miltenyi Biotec

Mercedes Romano Rodriguez, Senior Global Market Access Manager, ALK

Igor Rudychev, Vice President, Enterprise Analytics, Horizon

Sandrine Ruiz, Director Global Market Access and Pricing, Independent

Rachele Saccon, Engagement Manager, Lifescience Dynamics Ltd

Marcelo Sal, Head of Market Access and Pricing, South Cone of South America, PTC Therapeutics

Steve Sandor, Vice President of Market Access and Trade, Paratek Pharmaceuticals , Inc.

Andrew Satherley, Joint Managing Director, Lightning Health Ltd

Cathrin Schaefer, Senior Director Market Access, Sub-region Europe, BeiGene

Sophie Schmitz, Managing Partner, Partners4Access

Michael Schroter, Co-Head Sustainable Healthcare Equity, HSBC

Richard Sear, Director, Dolon

Ayman Semaan, Market Access & Pricing Lead, Biologix and Director of Communication - ISPOR Lebanon Chapter, BIOLOGIX

Hans Severens, Scientific adviser, Severens HTA consultancy

Navin Sewak, Global Market Access Director, ViiV Healthcare

Adelaide Shaw, Market Access Consultant, Initiate Consultants

Simon Shohet, Market Access, Amicus Therapeutics

Maartje Smulders, Sr Director RWE, Astellas

Igor Solev, Global Head of Market Access, Policy & External Payor Affairs, Abbott Laboratories

Ulf Staginnus, VP intl. market Access & Pricing, Blueprint Medicines

Helen Stoop, Head of Patient Advocacy – Takeda Europe and Canada, Takeda

Bart Strzelec, Ops Associate, Inbeeo

Fisentzos Stylianou, Senior Analyst, Partners4Access

Teddy Sun, Evidence Generation Lead, Takeda

Jan Swiderski, Public Affairs & Advocacy Director, Ipsen

Iselin Dahlen Syversen, Head of Department New Methods, Sykehusinnkjøp HF

Monika Szkultecka-Debek, Vice President, Qualitas Vitae Institute Foundation

sameera tak, Operating Director, Aesara

Peter Takacs, Global Business Operations, Miltenyi Biotec B.V. & Co. KG

Sam Taylor, Emerging Markets Strategic Pricing Lead, Pfizer

Chris Teale, SVP Market Access, Ipsos Market Access

Luca Tofani, Director, Pricing and MArket Access, SIFI spa

Richard Tolley, Head of Market Access EU, Ipsos Market Access

Ariella Toren, Director Of Medicine And Medical Technologies, Hmos Department, Israel - Ministry Of Health

Ilona Torontali, Global Head Pricing and Reimbursement, Roche

Sheela Upadhyaya, Life Science Advisor in Rare Diseases & Special Advisor, Fipra

Bart Van Den Daele, Head of External Affairs – Director Market Access - Belux, Gilead Sciences

Silvia van der Flier, Medical Advisor, VGZ

Goedele Van Haasteren, Staff Member, Swiss Federal Office of Public Health

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Medical Advisor, CZ

Kärt Veliste, Chief Specialist at Department of Medicines and Medical Devices, Haigekassa Estonia

Stefan Walzer, General Manager, MArS Market Access & Pricing Strategy, Germany

Jürgen Wasem, Professor for Health Services and Management, University Duisburg Essen

Grace Wayi-Wayi, Global Associate Director - Market Access, Eusa

Lara J Wolfson, Executive Director and Head of Hta Statistics, Merck

Claire Woon, Agency lead, AMICULUM Access

Natasa Zibelnik, Head of Market Access EMEA - Oncology, Menarini Group

Peter Zimmermann, Sr Director of Global Customer Success, Model N (Switzerland) GmbH

Zinajda Zolic-Karlsson, Senior advisor, Norwegian medicines agency

Zsombor Zrubka, Associate Professor - Department Of Health Economics, Obuda University

2023 Sponsors

TITLE SPONSOR:
• Lifescience Dynamics

PLATINUM SPONSORS:
• AliraHealth
• Parexel
• Valid Insight

GOLD SPONSORS:
• Access Infinity
• Eversana
• Ipsos
• Open Health
• P4A
• Remap

SILVER SPONSORS:
• Ascenian
• Cogentia
• CE
• Cube
• Dolon
• Genesis Research
• Global Pricing
• Health Lumen
• Human Data Sciences
• Inbeeo
• Initiate
• Lightning Health
• Logex
• Mktxs
• The Negotiation Lab
• Model N
• Pharma Business Partners
• Precision Advisors
• RX Data
• Vistex

BRONZE SPONSORS:
• Aesara
• Access
• FingerPost
• Red Nucleus